Inventor · disambiguated record
Markus Grompe
Also filed as: GROMPE MARKUS
11 granted patents·10 pending applications·34 citations·filing 1997–2020
86Inventor score
Files withGROMPE MARKUS7DANA FARBER CANCER INST INC6UNIV OREGON HEALTH & SCIENCE2D ANDREA ALAN1DANA-FARBER CANCER INSTITUTE INC1
Top patents by PatentIndex Score
21 records- 0185US9000257B2Fumarylacetoacetate hydrolase (fah)-deficient pigs and uses thereofGROMPE MARKUS·Filed 2011·Granted Apr 7, 2015·10 cites·15 claims
- 0278US9485971B2Fumarylacetoacetate hydrolase (Fah)-deficient pigs and uses thereofMAY FOUND FOR MEDICAL EDUCATION AND RES·Filed 2015·Granted Nov 8, 2016·3 cites·9 claims
- 0378US8569573B2Method of expanding human hepatocytes in vivoGROMPE MARKUS·Filed 2008·Granted Oct 29, 2013·7 cites·27 claims
- 0477US8247186B2Monoclonal antibodies and their useGROMPE MARKUS·Filed 2011·Granted Aug 21, 2012·3 cites·29 claims
- 0566US2020140868A1Compositions and methods for treating cancerDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 0660US10738310B2Treating cancer deficient in FANCA, FANCD2, FANCE, or FANCG with an ATM inhibitorDANA-FARBER CANCER INSTITUTE INC·Filed 2015·Granted Aug 11, 2020·0 cites·13 claims
- 0759US9354224B2Methods and compositions for the diagnosis of cancer susceptibilities and defective DNA repair mechanisms and treatment thereofDANA FARBER CANCER INST INC·Filed 2014·Granted May 31, 2016·0 cites·2 claims
- 0859US2011171216A1Monoclonal antibodies specific for pancreatic neoplasia cellsSTREETER PHILLIP R·Filed 2009·Application pending·0 cites
- 0957US2009062196A1Compositions and methods of treating cancerD ANDREA ALAN·Filed 2007·Application pending·0 cites
- 1056US7981628B2Monoclonal antibodies and their useUNIV OREGON HEALTH & SCIENCE·Filed 2007·Granted Jul 19, 2011·0 cites·32 claims
- 1153US9566315B2Normalization of the enterohepatic circulation in animals with a chimeric humanized liverGROMPE MARKUS·Filed 2014·Granted Feb 14, 2017·0 cites·2 claims
- 1253US2013157294A1Methods and Compositions for the Diagnosis of Cancer Susceptibilities and Defective DNA Repair Mechanisms and Treatment ThereofDANA FARBER CANCER INST INC·Filed 2012·Application pending·0 cites
- 1352US11421218B2Methods for enhancing the efficiency of gene editingDANA FARBER CANCER INST INC·Filed 2017·Granted Aug 23, 2022·0 cites·7 claims
- 1452US2022204988A1Promoter sequence and related products and uses thereofUNIV OREGON HEALTH & SCIENCE·Filed 2020·Application pending·0 cites
- 1549US8097428B2Monoclonal antibodies and their useGROMPE MARKUS·Filed 2011·Granted Jan 17, 2012·0 cites·32 claims
- 1648US2011257036A1Methods and Compositions for the Diagnosis of Cancer Susceptibilities and Defective DNA Repair Mechanisms and Treatment ThereofDANA FARBER CANCER INST INC·Filed 2010·Application pending·0 cites
- 1746US6132708ALiver regeneration using pancreas cellsUNIV OREGON HEALTH SCIENCES·Filed 1997·Granted Oct 17, 2000·11 cites·16 claims
- 1845US2017105395A1Normalization of the enterohepatic circulation in animals with a chimeric humanized liverGROMPE MARKUS·Filed 2016·Application pending·0 cites
- 1943US2003188326A1Methods and compositions for the diagnosis of cancer susceptibilities and defective DNA repair mechanisms and treatment thereofDANA FARBER CANCER INST INC·Filed 2002·Application pending·0 cites
- 2042US2012045764A1Method of expanding human hepatocytes in vivoGROMPE MARKUS·Filed 2010·Application pending·0 cites
- 2131US2003093819A1Methods and compositions for the diagnosis of cancer susceptibilities and defective DNA repair mechanisms and treatment thereofFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Markus Grompe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →